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Abstract
The canonical Wnt signaling pathway is highly conserved in evolution, widely used throughout
animal development, and frequently hyperactive in cancer. Although Wnt signaling has been the
subject of extensive genetic analysis in the past, some 200 genes have now been identified as
candidate modulators of this pathway by a recent study using high-throughput RNAi screening. 
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The discovery of small interfering RNAs (siRNAs), in con-
junction with whole-genome sequence data, has spawned a
21st-century strategy for carrying out surrogate genetics on a
grand scale - high-throughput RNA interference (RNAi)
analysis [1,2]. Using libraries of siRNAs that target poten-
tially all transcripts, one can screen for the phenotypic
effects of knocking down individual genes on a genome-wide
scale. Perhaps more than any other technique, high-
throughput RNAi encapsulates the full meaning of func-
tional genomics. DasGupta and colleagues [3] have recently
described the use of such screening for identifying genes that
modulate one of the major signal transduction mechanisms
in animal cells, the Wnt/-catenin pathway. 
Wnt proteins activate one of the most frequently encountered
intracellular signaling pathways in all of developmental
biology: one that has innumerable roles in the development
of multicellular animals, from sea anemones to humans [4].
The Wnt family of secreted signaling factors is also one of
the most ancient, pre-dating the divergence of cnidarians
and bilateral metazoans 650 million years ago [5]. In
mammals, besides its importance in embryogenesis and
postnatal development, Wnt signaling is also of major
medical significance. Aberrant activation of Wnt signaling is
an initiating or contributing factor in a wide range of human
cancers, including most colorectal cancers, and mutations in
components of the pathway have been associated with
specific hereditary diseases such as bone-density defects,
failure of tooth development, and vascular defects in the eye
[4,6,7]. At the cellular level, Wnt signaling is perhaps best
known for its effects on cell-fate decisions, although in different
settings it can regulate cell proliferation, apoptosis, differen-
tiation, adhesion, and migration [4,6]. Recent evidence also
implicates Wnt signaling in regulating the self-renewal of
pluripotent stem cells in various tissues, suggesting that it will
have a major role to play in stem-cell therapeutics [8].
The 19 different Wnt proteins in mammals share extensive
sequence similarity and many are functionally redundant.
Their principal signaling pathway involves -catenin as a key
signaling intermediate [4,6,7]. This pathway is variously
known as the Wnt/-catenin or canonical Wnt signaling
pathway, to distinguish it from non-canonical Wnt signaling
mechanisms that do not involve -catenin and which are
much less well characterized at present [9]. With intentional
simplification, our current understanding of the canonical
pathway can be reduced to the behavior of three multiprotein
complexes: the Wnt receptor complex at the cell surface, the
-catenin destruction complex in the cytoplasm, and the
-catenin/TCF (T-cell factor) transcription factor complex in
the nucleus (Figure 1). Wnt ligands interact with receptor
complexes composed of a seven-transmembrane-domain
Frizzled protein and one of the low-density lipoprotein
(LDL) receptor-related proteins LRP5 or LRP6. Formation
of a Wnt-Frizzled-LRP complex initiates a signal, via the
cytoplasmic proteins Dishevelled and Axin, which inhibits
the function of the -catenin destruction complex. The latter
normally serves to phosphorylate -catenin and so target it
for destruction by proteolysis. Wnt-mediated inhibition of
the destruction complex therefore results in stabilization of-catenin, which then accumulates in both cytoplasm and
nucleus. The nuclear fraction forms complexes with TCF pro-
teins and other factors, and directly activates the transcrip-
tion of diverse target genes whose promoters contain
TCF-binding sites. 
Many of the central elements of the canonical Wnt pathway
were originally identified in Drosophila through classical
genetic analysis of patterning in the fly embryo [10-12].
Here, the Drosophila Wnt1 ortholog (Wingless) signals via
the -catenin ortholog (Armadillo) to regulate the specific
fate of epidermal cells within each segment (see Table 1 for
details of the nomenclature differences between fly and
human). It seems appropriate that a signaling pathway
whose current framework is derived so much from conven-
tional genetics should be one of the first to be taken to a new
level of complexity by functional genomics and high-
throughput RNAi. The choice of Drosophila as the biological
system here has practical advantages. The lower complexity
of the genome predicts fewer redundancies among key com-
ponents and so improves the chances of detecting signaling
changes from the knockdown of individual genes. 
DasGupta  et al. [3] developed a high-throughput assay
based on the known ability of canonical Wnt signaling to
activate transcription of luciferase reporter constructs in
transfected cells. Improving on the widely used construct
TOP-Flash [13], they generated two new reporters each con-
taining multiple TCF-binding sites upstream of a different
minimal promoter. Because only the TCF sites were common
between the reporters, off-target effects unrelated to
-catenin/TCF signaling were minimized. Reporters with
mutated TCF-binding sites also served as specificity con-
trols. The authors first validated the behavior of these
reporters in transfection assays of Drosophila cell lines.
Then they scaled up the transfections to incorporate approx-
imately 22,000 double-stranded RNAs (dsRNAs), so as to
induce RNAi [3], and tested the individual effects on Wing-
less-induced signaling. The library of dsRNA sequences, pre-
viously used in other high-throughput RNAi screens, is
directed at all known open reading frames in the Drosophila
genome and is thought to be more than 95% complete
[14,15]. High-throughput screening was achieved in a
384-well plate format, with an individual RNA in each well,
together with transfection mixture, reporter plasmids, a
wingless-expressing plasmid, and the Drosophila cells. After
5 days, luciferase activity was measured in the wells and a
variety of statistical parameters were applied to highlight
those RNAs that had the most credible effects on reporter
activity. Of these, 238 were identified and re-tested in sec-
ondary screens. Their ability to modulate reporter activity
was verified in 213 cases, an impressive proportion (90%) of
the primary screen’s harvest.
Reassuringly, this protocol rounded up most of the ‘usual
suspects’ - that is, key components of the pathway already
known to regulate Wingless signaling. These included wing-
less itself,  frizzled,  arrow,  dishevelled,  axin,  armadillo
(-catenin),  pangolin (dTCF), and eight others, although
absent from the list were Dfz2 (Frizzled2),  APC, and
zw3/shaggy (GSK3). Attention could then be confidently
turned to the nearly 200 new sequences identified, one of
the challenges being to find ways of prioritizing the genes
and to separate more effectively the wheat from the chaff.
The authors approached this in several ways. One was to
re-test the dsRNAs in additional Drosophila cells and to
focus on those that modulated reporter activity in two or
more different cell lines. Another was to test the ability of the
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Figure 1
Key components of the canonical Wnt/-catenin signaling pathway.
Complexes formed by a Wnt ligand, Frizzled receptor protein and LRP5
or LRP6 initiate signaling within the cytoplasm. The signal acts via
Dishevelled (Dvl) and Axin to inhibit the -catenin destruction complex
and thus increase the stabilization of -catenin (-cat) , which then
accumulates in the cytosol and nucleus. In the nucleus, -catenin forms a
complex with TCF proteins that activates the transcription of specific target
genes. For simplicity, Dvl and Axin are shown as part of the -catenin
destruction complex, but each protein can also be found associated with
the receptor complex. Components shown shaded in gray have an
inhibitory effect on downstream signaling in the nucleus. The
nomenclature used is as for mammalian cells (see Table 1 for the
nomenclature of equivalent components in Drosophila). APC, the
adenomatous polyposis coli protein; GSK3, glycogen synthase kinase 3. 
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TranscriptiondsRNA to affect the TCF-luciferase reporter in the absence of
Wingless ligand. As the positive sequences here affect baseline
activity of the pathway, or perhaps the expression of key
components, some may be of less interest than the 37% that
specifically modulate Wingless-induced signaling.
Clues to possible functions of the approximately 200 new
candidate modulators were obtained from functional annota-
tions assigned by the Gene Ontology Consortium and from
the presence of protein domains identified by the InterPro
database. This allowed tentative grouping into functional
categories. The most numerous of these were transcription
factors, including several HMG-box proteins (the group to
which TCF proteins belong), homeodomain-containing
proteins, Taf family proteins (TATA-binding protein-asso-
ciated factors), and the basic helix-loop-helix (bHLH) protein
Twist. The latter has previously been identified as a target
gene of Wnt/-catenin signaling [16,17] and its identification
here as a negative regulator therefore suggests the possibility
of a negative feedback mechanism. Other prominent functional
categories included kinases and phosphatases, small GTPases,
RNA-binding proteins, and proteins containing Armadillo
repeats. The latter contain sequences related to the protein-
interaction motifs found in Armadillo/-catenin, but which can
be associated with a variety of cellular functions.
In several cases it was possible to obtain preliminary evidence
of where in the pathway the new players act, relative to known
landmarks. This was achieved by the equivalent of epistasis
tests in transfection assays. These experiments asked whether
dsRNA targeting a candidate positive regulator could block
signaling in the presence of positive stimuli downstream of
Wingless, such as expression of the activated co-receptor
LRP6, Dishevelled, or stabilized mutant -catenin. The results
showed, for example, that the gene product Dimerization
Partner (DP) functions upstream of -catenin. As DP is a
transcription factor, a result such as this could potentially
imply that DP plays a role in transcription of -catenin,
rather than being a direct component of the signaling
pathway. In contrast, Lilli, a transcription factor known to
interact genetically with armadillo [18], was placed down-
stream of -catenin and is a stronger candidate for direct
involvement in Wnt-induced transcriptional regulation.
Another computational approach for analyzing the dataset
was to use the Reciprocal-Best-BLAST method to identify
human orthologs of the 213 candidate modulators. This was
successful in approximately 50% of the cases. Besides the
obvious mammalian relevance of those that ‘made the cut’,
these are also more likely to be ubiquitous components or
modulators of the pathway. This is because virtually all the
key elements of the canonical Wnt pathway known so far are
well conserved between flies and humans. In some cases, the
authors validated the functional significance of the human
orthologs in vertebrate systems by testing their ability to
modulate TCF-luciferase reporter activity in human 293T
cells. The most impressive of these was the human homolog
of the gene named CG4136, which encodes a paired-like
homeobox protein. This same sequence, when expressed in
zebrafish embryos by injection of RNA at the single-cell
stage, gave a developmental phenotype similar to that of Wnt8,
indicating that it has a positive effect on Wnt signaling in a
variety of systems, both invertebrate and vertebrate.
One of the negative regulators identified in the screen was
Rab5, a small GTPase known to have a major role in the for-
mation of endocytic vesicles and their subcellular distribu-
tion [19]. This is of particular interest in view of extensive
current research into the local modulation of Wnt signaling
within cells and tissues by the surface availability of Wnt
ligands and receptors, and the subcellular localization of
other components [20]. DasGupta and colleagues [3] con-
firmed the antagonistic effect of Rab5 on Wingless-mediated
signaling in cells, and found that it had similar effects in
Drosophila when ectopically expressed in the wing imaginal
disk. How it exerts these effects remains to be seen, as it
caused no obvious change in the extracellular distribution of
Wingless protein as revealed by immunofluorescence. It
remains possible, however, that Rab5 affects the surface dis-
tribution of Wingless receptor components, or perhaps a
critical subset of Wingless molecules that is distinct from the
bulk fraction detected by antibody staining.
In highlighting the importance of the high-throughput RNAi
screen by DasGupta et al. [3], and the promise that it offers
for finding new signaling components, it is also worth con-
sidering the genes that were not found by this approach. A
number of other signaling pathways have been reported to
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Table 1
Principal components of the Wingless signaling pathway in
Drosophila and their human orthologs
Drosophila Human
Wingless Wnts  1-16
Frizzled2 Frizzleds 1-10
Arrow LRP5, and LRP6
Dishevelled Dvl-1, Dvl-2, and Dvl-3
Axin Axin-1 and Axin-2
APC, APC2 APC and APC2
Zw3/Shaggy GSK3
Armadillo -catenin
Pangolin/dTCF TCFs 1-4
There is greater redundancy of Wnt pathway components in humans than
in Drosophila. In addition to Wingless and Frizzled2, there are six other
Wnt proteins in Drosophila and three other Frizzled family members. In
contrast, humans have 16 Wnts and 10 Frizzleds. There are two APC
paralogs in both species, but other components downstream of Frizzled
in Drosophila are unique. APC, the adenomatous polyposis coli protein;
GSK3, glycogen synthase kinase 3; Zw3, zeste-white 3. exhibit cross-talk with Wnt/-catenin signaling or to inter-
act with specific components so as to modulate signaling.
These include the Notch pathway, the phosphatidylinositol
(PI) 3-kinase pathway, and pathways activated by certain
tyrosine kinase receptors [21-24]. Non-canonical modes of
Wnt signaling may also regulate the canonical Wnt/-catenin
pathway, possibly by acting through Nemo or Nemo-like
kinase [25,26]. No high-throughput screen of the sort dis-
cussed here is flawless but, given its success in finding most
of the known components of Wingless signaling, it is
perhaps surprising that there is little evidence of these other
interacting pathways in the dataset. In some cases it is possi-
ble that the modulation of Wnt/-catenin signaling by these
pathways is only seen in specific cellular contexts, that func-
tional redundancy precludes their detection, or that they have
a relatively minor role. Alternatively, their effects may have
been masked by the presence of Wingless in the primary
screen. This could be an explanation in the case of Notch, as
dsRNA targeted against Notch can substantially induce TCF-
reporter activity in transfection assays very similar to those
used here, but performed in the absence of Wingless [23].
Absence of these predicted modulators may also reflect the
reduced sensitivity or reliability of a high-throughput screen
relative to individual low-throughput experiments.
From the long list of new potential regulators of Wnt signal-
ing revealed by this study, many readers will have their own
most interesting candidates and some may wish to explore
the dataset more directly. To facilitate this, there is a search-
able database of this and other high-throughput RNAi
screens at the Drosophila RNAi screening center’s website
[27]. The site also includes other useful resources and links
relating to RNAi screening in general. Public availability of
RNAi datasets such as these will be a crucial aspect of their
future value. While some individual sequences from the
screens will undoubtedly rise to prominence through further
experimental analysis of their individual roles, the significance
of others will be likely to emerge through computational
integration of functional genomics data from related screens.
As a result of high-throughput RNAi screening, the canoni-
cal Wnt signaling pathway has suddenly become wider, with
a large new batch of contenders for inclusion. The bad news
is that the signaling diagrams will be getting more crowded
and complex. The good news is that computational biology
will take us closer to a more realistic view of signal trans-
duction and modulation in vivo. Given the immense bio-
medical implications of manipulating Wnt signaling in the
treatment of cancer and other diseases, as well as in stem-
cell therapies, functional genomics will help us to do this
more intelligently.
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